Scott L. Wilhoit is Chief Commercial Officer of Strongbridge Biopharma plc. Currently has a direct ownership of 0 shares of SBBP, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 109,510 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Scott L. Wilhoit Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
SELL
Sale (or disposition) back to the issuer
-
109,510 Reduced 100.0%
0 Ordinary Shares
Oct 01 2021
SELL
Payment of exercise price or tax liability
$56,681 $2.06 p/Share
27,515 Reduced 20.08%
109,510 Ordinary Shares
Feb 22 2021
SELL
Payment of exercise price or tax liability
$25,778 $3.62 p/Share
7,121 Reduced 4.94%
137,025 Ordinary Shares
Jan 07 2021
BUY
Grant, award, or other acquisition
-
113,000 Added 43.94%
144,146 Ordinary Shares
SLW

Scott L. Wilhoit

Chief Commercial Officer
Trevose, PA

Track Institutional and Insider Activities on SBBP

Follow Strongbridge Biopharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBBP shares.

Notify only if

Insider Trading

Get notified when an Strongbridge Biopharma PLC insider buys or sells SBBP shares.

Notify only if

News

Receive news related to Strongbridge Biopharma plc

Track Activities on SBBP